Search Results for 'risk adherence'

risk adherence published presentations and documents on DocSlides.

Statin Adherence Purpose

Statin Adherence Purpose

by ivy

Outline the issue of medication nonadherence and r...

Promoting Adherence and Retention in ARV-based Prevention

Promoting Adherence and Retention in ARV-based Prevention

by briana-ranney

Dr. Seema Sahay, Ph.D. Division of Social and Beh...

Medication Adherence in Chronic Cardiovascular Disease

Medication Adherence in Chronic Cardiovascular Disease

by mitsue-stanley

Doyle M. Cummings, PharmD, FCP, FCCP. Professor o...

Medication Adherence in Chronic Cardiovascular Disease

Medication Adherence in Chronic Cardiovascular Disease

by faustina-dinatale

Doyle M. Cummings, PharmD, FCP, FCCP. Professor o...

Medication Adherence and Persistence

Medication Adherence and Persistence

by emery

PrEP Counseling Center. What is Medication Adheren...

PrEP Training for

PrEP Training for

by tatyana-admore

Providers in Clinical Settings. 2. Welcome!. Plea...

LUMI Technology Question Slides

LUMI Technology Question Slides

by alexa-scheidler

The Pathway Conundrum: How Many Do We Need and Ho...

LUMI Technology Question Slides

LUMI Technology Question Slides

by olivia-moreira

The Pathway Conundrum: How Many Do We Need and Ho...

It’s Elementary VALIANT

It’s Elementary VALIANT

by luanne-stotts

High Early Risk of SCA. Patients With Low EF Foll...

Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions

Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions

by pamella-moone

Guidelines for the Use of Antiretroviral Agents i...

PrEP Training for Providers in Clinical Settings

PrEP Training for Providers in Clinical Settings

by luanne-stotts

(Version 2.0). 2. Welcome!. Please sign the regis...

Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions

Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions

by genesantander

Guidelines for the Use of Antiretroviral Agents in...

PrEP Training for Providers in Clinical

PrEP Training for Providers in Clinical

by luanne-stotts

PrEP Training for Providers in Clinical Setting...

Module 1: INTRODUCTION TO ORAL

Module 1: INTRODUCTION TO ORAL

by pamella-moone

PrEP. Version. : December . 2018. Outline of tra...

Preexposure Prophylaxis (

Preexposure Prophylaxis (

by heartfang

PreP. ). for the Prevention of HIV. Amy L. Davis, ...

The cost-effectiveness of fixed-dose combinations for preventative cardiovascular pharmacotherapy

The cost-effectiveness of fixed-dose combinations for preventative cardiovascular pharmacotherapy

by danika-pritchard

MPH thesis - Tal Sharrock . BODE. 3. . Universit...

PrEP: A Daily Pill to Prevent HIV

PrEP: A Daily Pill to Prevent HIV

by liane-varnes

Dawn K. Smith, MD, MS, MPH. Division of HIV/AIDS ...

Oral pre-exposure prophylaxis (PrEP) for populations at sub

Oral pre-exposure prophylaxis (PrEP) for populations at sub

by giovanna-bartolotta

Dr.. Rachel Baggaley, HIV dept. WHO, Geneva. GNP...

Scientific writing

Scientific writing

by marina-yarberry

(81-933). Lecture 5: Discussion. Dr. Avraham Sam...

Schizophrenia in Teenagers and Young Adults

Schizophrenia in Teenagers and Young Adults

by karlyn-bohler

From the Johns Hopkins Clinical Schizophrenia Pro...

Considerations in Dual Eligible Home Care

Considerations in Dual Eligible Home Care

by alida-meadow

Jane Mohler, NP-C, MSN, MPH, PhD. Professor of Me...

The Bangkok Tenofovir Study

The Bangkok Tenofovir Study

by marina-yarberry

An HIV pre-exposure prophylaxis trial in Thailand...

Certificate III / IV in Fitness

Certificate III / IV in Fitness

by tatyana-admore

Session . 6. & 7. Applied Personal . Traini...

Addiction: A Chronic Brain Disease

Addiction: A Chronic Brain Disease

by celsa-spraggs

Flora Sadri, DO,MPH, FAAFP. Area Medical Director...

Adaptive non-inferiority

Adaptive non-inferiority

by cheryl-pisano

margins under observable non-constancy. Brett Han...

The Evidence – PrEP Effectiveness

The Evidence – PrEP Effectiveness

by lindy-dunigan

Module . 1(b). The Evidence in Detail. Session Ov...

ADOLESCENT PrEP STUDIES

ADOLESCENT PrEP STUDIES

by min-jolicoeur

. . Shorai. . Mukaka. , . MBchB. ...

PrEP : HIV Pre-exposure Prophylaxis

PrEP : HIV Pre-exposure Prophylaxis

by phoebe-click

Katherine Marx, MS, MPH, FNP-BC. June 2014. Discl...

A Reality Check on BP Goals and Optimizing Patient Adherence

A Reality Check on BP Goals and Optimizing Patient Adherence

by test

to Treatment. Introduction. BP Classification: JN...

PrEP 201: Beyond the Basics

PrEP 201: Beyond the Basics

by stefany-barnette

Joanne . Stekler. , MD MPH. Associate Professor o...

Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL

Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL

by tawny-fly

Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PRO...

Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL

Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL

by alida-meadow

Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PRO...

Statin Side effects Active treatment

Statin Side effects Active treatment

by ximena

Control. Relative risk. Absolute Effect. (per thou...

by amelia

- Hady , et al Prevalence, risk factors, co...

WHERE ARE WE NOW? What are the big risks

WHERE ARE WE NOW? What are the big risks

by reese

and big opportunities. for children?. Prof. Lorrai...

Social and Behavioural aspects of Pharmacy Practice

Social and Behavioural aspects of Pharmacy Practice

by williams

FALL 2014/15. Pharmacists . have to deal with many...

Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL PrEP TO AGYW

Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL PrEP TO AGYW

by sophie

Version. : June 2019. Outline of training. Module ...